Examples of using Aurase in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Aurase acts very specifically on the protein fibrin.
BRAIN: What positive effects do you expect from the Aurase products?
Aurase is a medical product, and this is admittedly an unusual market segment for BRAIN.
BRAIN: What advantages does the Aurase enzyme offer as compared with other enzymatic active substances?
BRAIN has explored the connection anddeveloped a biological wound management based on the Aurase enzyme.
BRAIN: When do you intend to launch Aurase products on the market, and what business model will you use?
Tanja Klumpp:I am currently devising methods that enable us to analyse the Aurase production process.
With BRAIN's technological know-how, Aurase(R) development has already made significant progress.
Bela Kelety: On the one hand, we are presently working to optimise the yield of the biotechnological production system for the Aurase enzyme.
BRAIN's researchers found a model for the Aurase development in the wide-spread common green bottle fly Lucilia sericata.
Aurase, which has been developed by BRAIN, is a nature-based enzyme from the family of serine proteases, which can cleave proteins and peptides.
Experts estimate the annual salesvolume of the market that BRAIN can address for Aurase-based products at more than EUR 100 million in Europe alone.
Alexander Pelzer: The Aurase developed by BRAIN is an enzyme derived from the serin protease family that can break down proteins or peptides.
In the meantime, development activities in BRAIN's laboratories are well advanced andthey are targeted at achieving a clearly enhanced production method for Aurase.
We intend to show that Aurase products work under real-life nursing conditions and offer clear advantages for patients, nursing staff and doctors.
Currently, BRAIN is evaluating concrete application possibilities for Aurase and is engaged in discussions with industrial partners regarding different marketing strategies.
Aurase will be easy to use and fit smoothly into existing wound management processes at hospitals, nursing homes or nursing care at home.
We characterised this enzyme, which we later termed Aurase, and then developed a biotechnological process to produce it in large volumes with a high degree of purity.
Aurase offers the possibility to improve the efficient and conservative treatment of chronic wounds in hospitals and surgeries as well as in home-based health care.
A wound gel containing Aurase as an active ingredient has proved to be favourable, and has been shown to be effective and well-tolerated in pre-clinical trials.